Passions

Traveling

Cidermaking

Fishing

Experience

Alto Neuroscience Announces $147.9 Million IPO

February 6, 2024

Cooley advised Alto Neuroscience, a company redefining psychiatry by leveraging individuals’ neurobiology to develop personalized and highly effective medicines and helping patients get better faster, on its $147.9 million initial public offering.

Read more

Related contacts

Div Gupta
Partner, New York
Christina T. Roupas
Partner in Charge – Chicago, Chicago
Courtney M.W. Tygesson
Partner, Chicago
Laurie Bauer
Partner, Chicago
Nyron J. Persaud
Partner, New York
Dr. Jon Cousin
Partner, Washington, DC
Eileen Marshall
Partner, Washington, DC
Geoffrey Spolyar
Partner, Boston
Stephanie Gentile
Partner, New York
Steve Flores
Partner, Chicago
Peter Adams
Partner, San Diego
Phil Mitchell
Partner, New York
Courtney Thorne
Partner, London
Francis Wheeler
Senior Counsel, Colorado
Natasha Leskovsek
Of Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Dani Nazemian
Special Counsel, San Diego
Katie Lapidus
Associate, Washington, DC
Trey Reilly
Associate, New York
Adam Bloom
Associate, Chicago
Megan E. Bowles
Associate, Chicago
Edmond Lay
Partner, San Diego
Addison Pierce
Partner, Chicago
Calvin Lee
Associate, New York
Andrew Nelms
Associate, San Francisco
Jason Minio
Paralegal Specialist, Boston
Jeffery Wyzykowski
Patent Agent, Washington, DC

Related Practices & Industries

ACELYRIN Announces Pricing of Upsized Initial Public Offering

May 15, 2023

Cooley advised Acelyrin, INC., a late-stage biopharmaceutical company, in its $621 million initial public offering, the second-largest biotechnology IPO and largest clinical-stage biotechnology IPO ever.

Read more

Related contacts

Chadwick Mills
Partner, San Francisco
Charlie Kim
Partner, San Diego
Barbara Mirza
Partner, Santa Monica
Xander Lee
Partner, Santa Monica
Joshua Mates
Partner, San Francisco
Phil Mitchell
Partner, New York
Brad Goldberg
Partner, New York
Peter Adams
Partner, San Diego
Lauren Creel
Partner, Palo Alto
Koji Fukumura
Partner, San Diego
Patrick Gibbs
Partner, Palo Alto
David Peinsipp
Partner, San Francisco
Barbara Borden
Senior Counsel, San Diego
Patrick Van Eecke
Partner, Brussels
Shannon Eagan
Partner in Charge – Palo Alto, Palo Alto
Darren DeStefano
Partner, Reston
Francis Wheeler
Senior Counsel, Colorado
Thomas Welk
Senior Counsel, San Diego
Natasha Leskovsek
Of Counsel, Washington, DC
Dani Nazemian
Special Counsel, San Diego
Karen Tsai
Special Counsel, Washington, DC
Miriam Petrillo
Partner, Chicago
Andrew Nelms
Associate, San Francisco
David D. Kim
Associate, San Francisco
Lawrence Traylor
Associate, Santa Monica
Nathaniel Hearn Jr.
Associate, Chicago
Valerie Sapozhnikova
Associate, Los Angeles
Eileen Leman
Associate, Los Angeles
Kelly McCormick
Associate, San Francisco
Allison Kutner
Associate, New York
Madison (JJ) Meng
Associate, San Francisco
Rebecca Siegel
Associate, San Francisco
Mari Dugas
Associate, Washington, DC
Megan Drill
Associate, San Diego
Amanda Pacheco
Associate, Palo Alto
John T. Stellini
Associate, Palo Alto

Related Practices & Industries

Vera Therapeutics – $ 115 Million Follow-on Offering

February 1, 2023

Cooley advised Vera Therapeutics, a clinical-stage biotechnology company, on its $115 million follow-on offering of common stock. Partners Jodie Bourdet and Kristin VanderPas led the Cooley team.

Related contacts

Kristin VanderPas
Partner, San Francisco
Andrew Nelms
Associate, San Francisco
Mika Reiner Mayer
Partner, Palo Alto
Kimberly Bolin
Patent Agent, Palo Alto

Related Practices & Industries

Admissions and credentials

California

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.